Citation Impact
Citing Papers
Genomic Analysis of a Spontaneous Model of Breast Cancer Metastasis to Bone Reveals a Role for the Extracellular Matrix
2005
Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface
2010
Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Therapeutic Immunity by Adoptive Tumor-primed CD4+ T-cell Transfer in Combination With In Vivo GITR Ligation
2009 StandoutNobel
Regulation of cancer cell migration and bone metastasis by RANKL
2006 Nature
Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma
2000
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
2009 Standout
Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis
2013
Cancer to bone: a fatal attraction
2011 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit
2006 StandoutNobel
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
2003 StandoutNature
Cancer Metastasis: Building a Framework
2006 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese
2013
New insight in the pathobiology of hepatitis B virus infection
2012
Cytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease
2004
Secreted and Transmembrane Wnt Inhibitors and Activators
2012
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
A microRNA program in the C. elegans hypodermis couples to intestinal mTORC2/PQM-1 signaling to modulate fat transport
2016 StandoutNobel
Osteoporosis: now and the future
2011 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Cell Death in Pancreatitis
2005
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
2009 Standout
Non-alcoholic fatty liver disease
2021 Standout
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
2007 StandoutNature
Wnt/β-Catenin Signaling and Disease
2012 Standout
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
2012
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Selective Ablation of Retinoblastoma Protein Function by the RET Finger Protein
2005
Emerging Biological Principles of Metastasis
2017 Standout
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
2007
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells
2011
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Hepatic expression and cellular distribution of the glucose transporter family
2012
Dormancy in breast cancer
2012
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
2004
Future directions of bone-targeted therapy for metastatic breast cancer
2010
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Selective Blockade of the Capsaicin Receptor TRPV1 Attenuates Bone Cancer Pain
2005 StandoutNobel
Cyclins and cdks in development and cancer: a perspective
2005
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21
2015 StandoutNobel
Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans
2007
Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease
2005
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy
2016
MAB-10/NAB acts with LIN-29/EGR to regulate terminal differentiation and the transition from larva to adult in C. elegans
2011 Nobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Mouse 4T1 Breast Tumor Model
2000
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics
2015
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis
2009
Bone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
2010
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
Light-Controlled Radical Polymerization: Mechanisms, Methods, and Applications
2016 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients
2005
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
A Mouse Model of Human Breast Cancer Metastasis to Human Bone
2005
Granulocyte Macrophage Colony-Stimulating Factor
2001
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease
2001 Science
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Palaeoproteomic evidence identifies archaic hominins associated with the Châtelperronian at the Grotte du Renne
2016 StandoutNobel
Works of John Slavin being referenced
A novel orthotopic model of breast cancer metastasis to bone
1999
Induction of a Multiple Sclerosis-Like Disease in Mice with an Immunodominant Epitope of Myelin Oligodendrocyte Glycoprotein
1998
Inflammatory mediators in acute pancreatitis
2000
Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice
2009
Altered Immune System Glycosylation Causes Colitis in α1,2-Fucosyltransferase Transgenic Mice
2004
Expression and localization of GLUT1 and GLUT12 in prostate carcinoma
2003
Serum Hepatitis B Surface Antigen and Hepatitis B E Antigen Titers: Disease Phase Influences Correlation With Viral Load and Intrahepatic Hepatitis B Virus Markers
2010
Differential expression of GLUT12 in breast cancer and normal breast tissue
2003
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
2004
Associations Between Liver Histology and Severity of the Metabolic Syndrome in Subjects With Nonalcoholic Fatty Liver Disease
2005
Parathyroid Hormone–Related Protein Localization in Breast Cancers Predict Improved Prognosis
2006
Osteoprotegerin Overexpression by Breast Cancer Cells Enhances Orthotopic and Osseous Tumor Growth and Contrasts with That Delivered Therapeutically
2006